The review compiled and analyzed all published data on Middle East respiratory syndrome (MERS) in the global camel population to provide an overview of current knowledge on the distribution, spread and risk factors of infections in dromedary camels.
Monday, February 25, the Saudi Ministry of Health (MOH) announced the 50th Middle East respiratory syndrome (MERS) case since January 29th in the town of Wadi Aldwasir (pop 106,000), located about 500 km south of Riyadh.
Over the weekend and through Monday, February 11, the Ministry of Health of Saudi Arabia recorded 10 more cases of Middle East respiratory syndrome (MERS), including seven in an ongoing outbreak in Wadi ad-Dawasir.
Twenty people have been diagnosed with the Middle East respiratory syndrome-coronavirus (MERS-CoV) over the past few days in Saudi Arabia.
There has been substantial MERS-CoV research since 2012, but significant knowledge gaps persist, especially in epidemiology and natural history of the infection. There have been few rigorous studies of baseline prevalence, transmission, and spectrum of disease.
The announcement, on January 31, raises the Saudi Arabia total to 14 for the month of January.
This brings the total number of recorded cases from various governorates in the Sultanate to 18 since 2013.
Researchers surveilled camels in Egypt, Tunisia, and Senegal to include other domestic mammalian species in contact with infected camels.
A novel drug discovered by researchers from the University of Hong Kong was found effective in treating Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and A/H1N1 influenza, according to the university.
This case underscores the importance of a high index of suspicion of MERS-CoV infection in any febrile patients who present after a trip to the Middle East.